Flywheel's New Imaging Solution for Clinical Trials
Flywheel, a key player in the field of medical imaging data management, has recently unveiled its latest offering:
Flywheel Validated. This innovative solution is set to revolutionize the way clinical trials access and analyze imaging data. By improving the efficiency of data workflows and ensuring regulatory compliance, Flywheel Validated aims to empower pharmaceutical companies and researchers.
Overcoming Barriers in Clinical Trials
The launch of Flywheel Validated addresses a significant hurdle in clinical research—
the slow and fragmented access to high-quality data. This solution is specifically designed for organizations involved in regulated trials and those developing AI models in the medical space. It complies with
21 CFR Part 11, aiming to streamline imaging workflows for stakeholders such as pharmaceutical sponsors, contract research organizations (CROs), and medical centers.
According to
Shelby Wyatt, Chief Product Officer at Flywheel, the Flywheel Validated solution is a game-changer. Organizations can harness insights from imaging data earlier in the clinical trial process, thus allowing for timely adjustments based on real-time findings. Additionally, this tool enhances operational efficiency by automating checks and facilitating structured validated reads in a singular, user-friendly platform.
Features of Flywheel Validated
1. Guided Data Upload Experience
Flywheel Validated offers a user-friendly interface for site contributors, enabling smooth data uploads in multicenter studies. This reduces the chances of errors and inconsistencies in data entry, enhancing overall data quality.
2. Human-in-the-Loop Workflows
The solution incorporates human oversight during validated imaging reads, ensuring that crucial quality checks are conducted before data is utilized in trials. This approach improves the reliability of outcomes and fosters greater trust in the findings.
3. Comprehensive Compliance and Documentation
Flywheel Validated features capabilities for audit trails, project locking, and electronic signatures. These features not only help to maintain regulatory compliance but also assure stakeholders of the integrity of their data, essential for regulatory submissions.
4. Automated Processing Pipelines
The platform automates various steps of data aggregation, curation, and analysis. This not only saves time but also reduces the operational burden on researchers, allowing them to focus more on deriving insights from data.
Looking Ahead
Flywheel is set to showcase this comprehensive solution during the
GEN webinar on December 11, 2025, titled “Accelerating Clinical Decisions Through Faster Access to Imaging Data.” This event will detail how Flywheel Validated can facilitate quicker decision-making in clinical research environments.
Flywheel aims to enhance the healthcare landscape through its innovative applications of imaging data. The company’s mission centers on empowering stakeholders to maximize the value of their imaging assets, ultimately leading to better health outcomes.
In conclusion, Flywheel Validated stands as a promising development in the continual evolution of clinical trial processes. By focusing on regulatory compliance, efficient data access, and effective decision-making, this solution paves the way for more effective clinical research and, by extension, better healthcare solutions for patients worldwide.
For further information and to request a demo of the Flywheel Validated solution, visit
flywheel.io.